International Journal of Clinical Pharmacy (2019) 41:1570–1577

https://doi.org/10.1007/s11096-019-00922-3

RESEARCH ARTICLE

Iy
y
1 2 3 1 3 3 3 3
Yulin Zhu · Cheng Liu · Yong Zhang · Qingping Shi · Yiqiu Kong · Muqun Wang · Xuemei Xia · Feng Zhang

Received: 24 December 2018 / Accepted: 9 October 2019 / Published online: 25

October 2019 © The Author(s) 2019

Abstract
Background
ObjectiveSetting
Methods

Main outcome measures

Results%

Conclusion

Kyw

Impact on Practice Introduction

]
]

]
]

13
International Journal of Clinical Pharmacy (2019) 41:1570–1577\ 1571

]
]

Aim of the study

Ethics approval

] ]
]
]

Methods

T
χ
p

13
\1572 International Journal of Clinical Pharmacy (2019) 41:1570–1577

Results

Characteristics

± ± ±
± ± ±

Admission diagnosis

Concomitant diseases

Medication

Mean number of drugs taken ± ±

ppp

13
International Journal of Clinical Pharmacy (2019) 41:1570–1577\ 1573

±±p

I A

Discussion

13
\1574 International Journal of Clinical Pharmacy (2019) 41:1570–1577

] ]

]
]

13
International Journal of Clinical Pharmacy (2019) 41:1570–1577\ 1575

13
\1576 International Journal of Clinical Pharmacy (2019) 41:1570–1577

] ]

]
]

13
International Journal of Clinical Pharmacy (2019) 41:1570–1577\ 1577

Conclusion

References

13